Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health services tags : Genomic save search
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
Published: 2024-01-08 (Crawled : 09:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M
|
Health Services
|
| O: 2.99%
H: 1.81%
C: 1.36%
health genomic cancer africa
Global Precision Oncology Research Report 2023-2031: Liquid Biopsies, Genomic Breakthroughs, AI-Driven Insights - Revolutionizing Cancer Monitoring and Diagnosis
Published: 2023-08-30 (Crawled : 17:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 1.36%
H: 0.0%
C: 0.0%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -2.32%
H: 0.0%
C: 0.0%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.24%
H: 0.87%
C: -0.12%
report genomic cancer research global
Global Next Generation Sequencing (NGS) Market Analysis 2023: A $28.47 Billion Market by 2033 - Untapped Potential with Ongoing Technological Developments and Genomic Healthcare Integration
Published: 2023-07-21 (Crawled : 16:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.07%
H: 4.84%
C: 4.37%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.13%
H: 2.65%
C: 2.24%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.72%
H: 6.23%
C: 5.46%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 3.01%
C: 2.46%
TWST | $27.92 -1.55% -1.58% 1.1M
|
Health Technology
|
| O: 2.31%
H: 7.27%
C: 4.84%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.13%
H: 2.65%
C: 2.24%
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: 0.45%
H: 2.26%
C: 0.98%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.57%
H: 3.4%
C: 2.85%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 1.28%
H: 0.0%
C: -6.2%
BNR | $0.72 -10.0% -11.11% 24K
|
Health Services
|
| O: 4.33%
H: 1.38%
C: -4.15%
integration genomic ongoing global potential market
Global Genomic Cancer Panel and Profiling Markets, 2023-2027: An Exploding Market as Physicians Use All the Information they Can Get in the Battle Against Cancer
Published: 2023-02-10 (Crawled : 01:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.81%
C: 0.76%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -1.8%
H: 1.83%
C: -4.59%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.18%
H: 0.94%
C: 0.88%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.18%
H: 0.59%
C: -0.09%
MLAB | $101.19 1.58% 1.55% 27K
|
Health Technology
|
| O: -0.73%
H: 2.8%
C: 2.25%
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: -0.66%
H: 1.6%
C: -0.18%
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
|
| O: -0.8%
H: 1.84%
C: 1.53%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 0.0%
H: 1.63%
C: 1.59%
TXG | $27.92 -3.56% -3.69% 2M
|
Health Technology
|
| O: -2.24%
H: 1.83%
C: 0.59%
global genomic cancer market
Global Genomic Cancer Panel and Profiling Markets, 2022-2026: Screening Potential Market Size, Customized Forecasting/Analysis, and Executive and Consultant Guides
Published: 2022-07-22 (Crawled : 20:00) - prnewswire.com
ANPCY | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
TXG | $27.92 -3.56% -3.69% 2M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NH | $1.35 -46.64% -1.48% 0
|
Technology Services
| Email alert
Add to watchlist
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
| Email alert
Add to watchlist
ANPCF | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
NVTA | $0.019 0.0% 22M
|
Health Services
| Email alert
Add to watchlist
global genomic potential cancer market
Global $3.25+ Billion Lung Cancer Genomic Testing Markets to 2031: Focus on Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.43%
H: 2.47%
C: 1.85%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 2.35%
H: 2.94%
C: 2.21%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 0.4%
H: 13.31%
C: 13.31%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 1.38%
H: 3.62%
C: 3.49%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 2.4%
H: 0.0%
C: 0.0%
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 0.75%
H: 15.68%
C: 15.57%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 5.62%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -4.76%
H: 34.5%
C: 3.0%
genomic cancer
Fresenius Medical Care Launches My Reason® Campaign to Enroll Patients in Groundbreaking Renal-focused Genomic Registry
Published: 2022-04-13 (Crawled : 13:20) - biospace.com/
FMS | $19.54 0.77% 0.0% 460K
|
Health Services
|
| O: 0.48%
H: 0.77%
C: 0.68%
reason care enroll genomic
Introducing Invitae Digital Health--A Personalized Health Management Platform That Leverages Genomic Insights to Inform Health Decisions for Patients and Clinicians
Published: 2022-03-29 (Crawled : 11:00) - prnewswire.com
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 2.35%
H: 8.71%
C: 6.89%
health genomic management platform
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer
Published: 2022-03-17 (Crawled : 10:00) - biospace.com/
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: -0.76%
H: 6.51%
C: 5.04%
genomics genomic cel lung cancer cancer
Fulgent Genetics Announces Strategic Investment in Spatial Genomics
Published: 2022-02-23 (Crawled : 23:00) - biospace.com/
FLGT | $20.34 1.14% 1.13% 160K
|
Health Services
|
| O: 1.81%
H: 0.95%
C: -5.14%
genetic genomics ces genomic
NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
Published: 2022-02-23 (Crawled : 13:00) - biospace.com/
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: 1.76%
H: 5.88%
C: -2.78%
genomics genomic report
NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer
Published: 2022-02-14 (Crawled : 13:00) - biospace.com/
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: -0.71%
H: 1.69%
C: -4.13%
genomics genomic
NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma
Published: 2022-02-11 (Crawled : 08:00) - biospace.com/
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: -1.5%
H: 0.0%
C: 0.0%
genomics genomic cel positive results positive results head and neck cell carcinoma
NeoGenomics First to Partner with Biomarker Collaborative and Deliver Patient Resources Along with Oncology Testing Results
Published: 2022-01-24 (Crawled : 13:00) - biospace.com/
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: -2.74%
H: 5.87%
C: 5.35%
genomics genomic liver test collaboration biomarkers
GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumors
Published: 2022-01-12 (Crawled : 20:00) - biospace.com/
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -1.49%
H: 0.0%
C: -1.67%
treatment solid tumors genomic trial potential work test
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
Published: 2021-12-23 (Crawled : 13:00) - biospace.com/
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.66%
H: 0.14%
C: -1.41%
diagnostic genomic diagnostics
NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary
Published: 2021-12-13 (Crawled : 10:00) - biospace.com/
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: -4.4%
H: 0.0%
C: 0.0%
genomics genomic
NeoGenomics to Leverage Thermo Fisher Scientific’s Ion Torrent Genexus System in Upcoming Phase 1 Study for Myeloid Cancer
Published: 2021-12-10 (Crawled : 12:30) - biospace.com/
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: -0.61%
H: 0.0%
C: 0.0%
genomics genomic phase 1 cancer phase 2
NeoGenomics To Participate In The Stephens Annual Investment Conference 2021
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: -4.18%
H: 0.0%
C: 0.0%
genomics genomic conference
NeoGenomics Appoints Dave Daly to Its Board of Directors
Published: 2021-11-10 (Crawled : 13:00) - biospace.com/
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.37%
H: 1.52%
C: 1.29%
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: -0.28%
H: 2.57%
C: -0.88%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.47%
H: 0.59%
C: -5.17%
genomics genomic
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.